---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-121603"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T21:04:16.657764+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Petros Pharma stockholders OK reverse stock split up to 1:25

## Summary
- Directors Silverman, Bernstein, Walker elected to one-year terms.
- Reverse stock split (range 1:2 to 1:25, Board discretion) approved; For 2,949,518, Against 1,350,781.
- Marcum LLP ratified as independent auditor for FY2024 with 3,984,099 for votes.
- Advisory say-on-pay proposal passed with 1,433,687 for votes.
- Adjournment proposal passed to allow further proxy solicitation if needed.

## SEC filing metadata
- accession: 0001104659-24-121603
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/0001104659-24-121603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/tm2429163d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-121603
- JSON: https://secwatch.observer/filing/0001104659-24-121603.json
- Plain text: https://secwatch.observer/filing/0001104659-24-121603.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.